József Csábi Selected Research

Ecdysteroids

1/2017	Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
1/2017	BBB penetration-targeting physicochemical lead selection: Ecdysteroids as chemo-sensitizers against CNS tumors.
1/2015	Ecdysteroids sensitize MDR and non-MDR cancer cell lines to doxorubicin, paclitaxel, and vincristine but tend to protect them from cisplatin.
12/2013	Synthesis and structure-activity relationships of novel ecdysteroid dioxolanes as MDR modulators in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

József Csábi Research Topics

Disease

4	Neoplasms (Cancer) 01/2017 - 12/2013
1	Neuroblastoma 01/2017
1	Lymphoma (Lymphomas) 01/2015

Drug/Important Bio-Agent (IBA)

4	EcdysteroidsIBA 01/2017 - 12/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2015
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 01/2015
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Ecdysterone (20 Hydroxyecdysone)IBA 01/2015
1	DioxolanesIBA 12/2013

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2017